My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

SE Investments to hold AGM
Aug 21,2017

SE Investments announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2017.

Powered by Capital Market - Live News

Bombay Talkies schedules AGM
Aug 21,2017

Bombay Talkies announced that the Annual General Meeting (AGM) of the company will be held on 23 September 2017.

Powered by Capital Market - Live News

Bharti Airtel schedules EGM
Aug 21,2017

Bharti Airtel announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 19 September 2017.

Powered by Capital Market - Live News

Monte Carlo Fashions schedules AGM
Aug 21,2017

Monte Carlo Fashions announced that the Annual General Meeting (AGM) of the company will be held on 29 September 2017.

Powered by Capital Market - Live News

Zodiac-JRD-MKJ AGM scheduled
Aug 21,2017

Zodiac-JRD-MKJ announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2017.

Powered by Capital Market - Live News

Associated Alcohols & Breweries to conduct board meeting
Aug 21,2017

Associated Alcohols & Breweries will hold a meeting of the Board of Directors of the Company on 25 August 2017.

Powered by Capital Market - Live News

K-Lifestyle & Industries to convene AGM
Aug 21,2017

K-Lifestyle & Industries announced that the 30th Annual General Meeting(AGM) of the company on 29 September 2017.

Powered by Capital Market - Live News

RBI Introduces Rs 50 banknote in Mahatma Gandhi (New) Series
Aug 21,2017

The Reserve Bank of India will shortly issue Rs 50 denomination banknotes in the Mahatma Gandhi (New) Series, bearing signature of Dr. Urjit R. Patel, Governor, Reserve Bank of India. The new denomination has motif of Hampi with Chariot on the reverse, depicting the countrys cultural heritage. The base colour of the note is Fluorescent Blue. The note has other designs, geometric patterns aligning with the overall colour scheme, both at the obverse and reverse.

All the banknotes in the denomination of Rs 50 issued by the Reserve Bank in the earlier series will continue to be legal tender.

ii Salient Features

Obverse (Front)

1. See through register with denominational numeral 50,

2. Denominational numeral ५० in Devnagari,

3. Portrait of Mahatma Gandhi at the centre,

4. Micro letters RBI, भारत, INDIA and 50,

5. Windowed demetalised security thread with inscriptions भारत and RBI,

6. Guarantee Clause, Governors signature with Promise Clause and RBI emblem towards right of Mahatma Gandhi portrait,

7. Ashoka Pillar emblem on the right,

8. Mahatma Gandhi portrait and electrotype (50) watermarks,

9. Number panel with numerals growing from small to big on the top left side and bottom right side.

Reverse (Back)

10. Year of printing of the note on the left,

11. Swachh Bharat logo with slogan,

12. Language panel,

13. Motif of Hampi with Chariot,

14. Denominational numeral 50 in Devnagari.

Dimension of the banknote will be 66 mm x 135 mm.

Powered by Capital Market - Live News

Satia Industries to convene board meeting
Aug 21,2017

Satia Industries will hold a meeting of the Board of Directors of the Company on 26 August 2017, to consider and take on record the un-Audited Financial Results of the Company for the Quarter ended 30th June, 2017.

Powered by Capital Market - Live News

HDFC gains as subsidiary files DRHP with SEBI for IPO
Aug 21,2017

The announcement was made after market hours on Friday, 18 August 2017.

Meanwhile, the S&P BSE Sensex was down 175.99 points or 0.56% at 31,348.69

On the BSE, 46,000 shares were traded on the counter so far as against the average daily volumes of 3.14 lakh shares in the past one quarter. The stock had hit a high of Rs 1,745.25 and a low of Rs 1,730 so far during the day. The stock had hit a record high of Rs 1,799 on 1 August 2017 and a 52-week low of Rs 1,185 on 5 December 2016.

The large-cap company has equity capital of Rs 318.65 crore. Face value per share is Rs 2.

HDFC Standard Life Insurance Company, a material subsidiary of HDFC has on Friday, 18 August 2017 filed a draft red herring prospectus with Securities & Exchange Board of India for an initial public offer of up to 29.98 crore shares of Rs 10 each representing 14.97% of the paid-up equity capital of HDFC Standard Life Insurance Company through an offer for sale of 19.12 crore equity shares by HDFC and 10.86 crore equity shares by Standard Life (Mauritius Holdings).

HDFC had on 14 August 2017 said that consequent to the approval of the National Company Law Tribunal, the Insurance Regulatory and Development Authority of India has granted its final approval for the merger of HDFC ERGO General Insurance Company, a subsidiary of the company and L&T General Insurance Company.

HDFCs net profit fell 16.84% to Rs 1555.74 crore on 3% fall in total income to Rs 8141.76 crore in Q1 June 2017 over Q1 June 2016.

HDFC is Indias first retail housing finance company and is currently one of the largest originators of housing loans in the country.

Powered by Capital Market - Live News

TRF tumbles after recent sharp rally
Aug 21,2017

Meanwhile, the S&P BSE Sensex was down 188.01 points, or 0.6% at 31,336.67. The S&P BSE Small-Cap index was down 92.10 points, or 0.59% at 15,525.85.

On the BSE, 10,000 shares were traded on the counter so far as against the average daily volumes of 20,244 shares in the past one quarter. The stock had hit a high of Rs 223.25 and a low of Rs 206 so far during the day. The stock had hit a 52-week high of Rs 314.80 on 22 August 2016 and a 52-week low of Rs 181 on 9 November 2016.

The stock had underperformed the market over the past one month till 18 August 2017, declining 5.55% compared with the Sensexs 0.59% fall. The scrip had also underperformed the market over the past one quarter declining 10.74% as against the Sensexs 3.58% rise. The scrip had also underperformed the market over the past one year declining 24.3% as against the Sensexs 12.09% rise.

The small-cap company has equity capital of Rs 11 crore. Face value per share is Rs 10.

Shares TRF had rallied 15.39% in the preceding four trading sessions to settle at Rs 223.05 on Friday, 18 August 2017, from its close of Rs 193.30 on 11 August 2017.

TRF reported consolidated net loss of Rs 9.15 core in Q1 June 2017, compared with net profit of Rs 8.59 crore in Q1 June 2016. Net Sales rose 0.2% to Rs 243.17 crore in Q1 June 2017 over Q1 June 2016.

TRF is engaged in the production of material handling equipment. The Company segments include Products & Services, and Projects & Services.

Powered by Capital Market - Live News

PM to launch Rs 15000 crore road projects in Rajasthan
Aug 21,2017

Prime Minister Shri Narendra Modi will inaugurate / lay the foundation stone for National Highways projects worth nearly Rs 15000 crores in Rajasthan. The Prime Minister is scheduled to visit Udaipur on 29th of August, 2017. He will dedicate to the Nation eleven completed National Highways projects totalling a length of about 873 km. These include a 6-lane Cable Stayed Bridge across river Chambal at Kota. In addition to this he will perform Bhoomi Poojan for six NH projects of about 556 km.

Powered by Capital Market - Live News

Infosys slumps about 14% in two sessions
Aug 21,2017

Meanwhile, the S&P BSE Sensex was down 159.47 points, or 0.51% to 31,365.21.

On the BSE, 35.82 lakh shares were traded in the counter so far, compared with average daily volumes of 3.84 lakh shares in the past one quarter. The stock had hit a high of Rs 929 and a low of Rs 875.20 so far during the day. The stock hit a 52-week high of Rs 1,080.70 on 14 October 2016. The stock hit a 52-week low of Rs 875.20 on 21 August 2017.

The stock had underperformed the market over the past one month till 10 August 2017, falling 4.74% compared with 1.19% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 3.63% as against Sensexs 3.48% rise. The scrip had also underperformed the market in past one year, falling 9.60% as against Sensexs 12.28% rise.

The large-cap company has equity capital of Rs 1148.48 crore. Face value per share is Rs 5.

According to media reports, four US law firms would be investigating claims on behalf of Infosys investors whether some of the officers and directors of the company engaged in securities fraud. This development follows the sudden resignation of CEO Vishal Sikka and the steep drop in share prices on Friday, 18 August 2017.

Vishal Sikka resigned as managing director and chief executive officer of Infosys on Friday, 18 August 2017. The board has accepted his resignation with immediate effect, the IT major said in a statement issued during trading hours on Friday, 18 August 2017. Infosys said U.B. Pravin Rao, its chief operating officer, has been named as interim managing director and chief executive.

Shares of Infosys slumped 9.60% to settle at Rs 923.10 on Friday, 18 August 2017. The stock has fallen 13.98% in two sessions from its close of Rs 1,021.15 on 17 August 2017.

Dr Sikka cited personal attacks as one of the reasons for his surprise resignation in a letter to Infosys board members. In his notice of resignation to the board, Dr Sikka reiterated his belief in the great potential of Infosys, but cited among his reasons for leaving a continuous stream of distractions and disruptions over the recent months and quarters, increasingly personal and negative as of late, as preventing managements ability to accelerate the companys transformation, Infosys said in a statement.

The board understands and acknowledges Dr Sikkas reasons for resignation, and regrets his decision. In particular, the board is profoundly distressed by the unfounded personal attacks on the members of our management team that were made in the anonymous letters and have surfaced in recent months, Infosys added.

Meanwhile, Infosys board at its meeting held on Saturday, 19 August 2017, approved a proposal to buyback upto 11.30 crore shares, aggregating up to 4.92% of the paid-up equity capital, at Rs 1,150 per share. The maximum buyback size is Rs 13000 crore. The buyback price is at a premium of 24.58% over the stocks closing price of Rs 923.10 on the BSE on Friday, 18 August 2017.

Infosys consolidated net profit fell 3.3% to Rs 3483 crore on 0.2% decline in revenue to Rs 17078 crore in Q1 June 2017 over Q4 March 2017.

Infosys is a global leader in technology services and consulting.

Powered by Capital Market - Live News

Soil health cards should be printed in the local dialect of the area
Aug 21,2017

The Prime Minister, Shri Narendra Modi, reviewed the progress of two key schemes related to the agriculture sector - Soil Health Cards; and Pradhan Mantri Fasal Bima Yojana.

The Prime Minister was informed that 16 States/UTs have completed the first cycle of Soil Health Cards distribution, and the remaining States are likely to complete the same within weeks.

Reviewing the progress, the Prime Minister said that appropriate checks should be undertaken for variation, both within a sampling grid, and across different soil testing labs. This would help ensure quality in the reports, he added.

The Prime Minister also emphasized that soil health cards should be printed in the local dialect of the area, so that the farmers are able to read and understand them easily.

Encouraging the rapid adoption of latest technology, the Prime Minister said that soil testing should eventually be possible through hand-held devices. He urged officials to explore the possibility of involving start-ups and entrepreneurs in this exercise.

On Pradhan Mantri Fasal Bima Yojana, the Prime Minister was informed that in the Kharif season of 2016, and Rabi season of 2016-17, claims of over Rs. 7700 crore have already been paid, and over 90 lakh farmers have been benefited.

Officials also said that latest technology including smartphones, remote sensing, satellite data and drones are being used for speedy data collection with regard to crop insurance claims.

Powered by Capital Market - Live News

Suven Life Sciences sizzles after securing a product patent
Aug 21,2017

The announcement was made during market hours today, 21 August 2017.

Meanwhile, the S&P BSE Sensex was down 93.64 points or 0.3% to 31,431.04. The S&P BSE Small-Cap index was down 21.36 points, or 0.14% to 15,596.59.

On the BSE, 46,000 shares were traded in the counter so far, compared with average daily volumes of 35,605 shares in the past one quarter. The stock had hit a high of Rs 167.80 and a low of Rs 160 so far during the day. The stock hit a 52-week high of Rs 213.10 on 6 October 2016. The stock hit a 52-week low of Rs 151.10 on 9 November 2016.

The small-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced the grant of one product patent from Japan corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2034.

The granted claims of the patents include the class of selective 5-HT4 compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, Parkinson and Schizophrenia.

Net profit of Suven Life Sciences fell 9.24% to Rs 29.57 crore on 3.2% rise in net sales to Rs 137.45 crore in Q1 June 2017 over Q1 June 2016.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Powered by Capital Market - Live News